• Anima signs new strategic collaboration deal with Takeda pharmaceutical-business-review
    March 22, 2021
    Anima Biotech has announced its new strategic collaboration deal with Takeda Pharmaceutical Company for the discovery and development of new medicines to combat genetically defined neurological diseases.
  • Anima, Eli Lilly pen $1B-plus biobucks research pact fiercebiotech
    July 26, 2018
    Little-known private biotech Anima Biotech has signed a deal with Eli Lilly potentially worth more than $1 billion in biobucks as the pair seeks to work on the biotech’s translation inhibitors.
  • Lilly links with Anima pharmatimes
    July 25, 2018
    Eli Lilly is teaming up with Anima Biotech in an exclusive collaboration to discover and develop translation inhibitors for several protein targets.
PharmaSources Customer Service